August 27, 2025 | TECHNOLOGY
Insights into the AVA™ Emulation System: Ushering in a New Era of Human-Relevant Drug Discovery
As the company’s CEO, Jim Corbett brings a unique perspective on how AVA will accelerate adoption across pharma, biotech, and academia—and why it represents a turning point for human-relevant drug discovery.